Barclays Maintains Overweight on Marex Group, Raises Price Target to $92
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $86 to $92.
Stocks · News reference
UBS Maintains Buy on Marex Group, Raises Price Target to $90
UBS analyst Alex Kramm maintains Marex Group (NASDAQ:MRX) with a Buy and raises the price target from $82 to $90.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Marex announces changes to Group Board
Marex Group Limited announced that Chair Robert Pickering has stepped down after a three-year tenure that oversaw the company's transformation from a private firm to a NASDAQ-listed business with over $5 billion market capitalization. John Pietrowicz, former CFO of CME Group, has been appointed as the new Chair. The leadership transition comes as Marex continues its growth trajectory following its successful IPO in April 2024.
Piper Sandler Maintains Overweight on Marex Group, Raises Price Target to $80
'Cantor Lets Hedge Funds Place Big Bets on Kalshi’s Prediction Markets' - Wall Street Journal
https://www.wsj.com/finance/investing/cantor-lets-hedge-funds-place-big-bets-on-kalshis-prediction-markets-625d21e7